MedTrace Logo

EndoSearch : Endometriosis Biomarkers

NCT03376451 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 975

Last updated 2022-05-12

No results posted yet for this study

Summary

EndoSearch aims to analytically validate a cluster of specific biomarkers for endometriosis diagnosis and disease recurrence. This signature will be tested on endometrium and blood from 975 patients, divided in two groups : 550 patients affected by endometriosis and 225 patients unaffected (controls).

EndoSearch is not about drug or medical device assessment but a research study for biomarker analytical validation purpose.

Conditions

  • Endometriosis (Diagnosis)
  • Blood Biomarkers
  • Endometrium Biomarkers

Interventions

OTHER

Assessment of endometrium and blood biomarkers for endometriosis diagnosis

Biological samples will be collected from patients, sent to Endodiag, Paris, in France and be processed through IHC and molecular biology techniques to assess the ability of the identified biomarkers signature to diagnose and prognose endometriosis.

Sponsors & Collaborators

  • Dr Afchine Fazel

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2022-09-01
Completion
2022-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03376451 on ClinicalTrials.gov